Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide
We report a 34‐year‐old woman with recurrent gestational trophoblastic neoplasia (GTN) who showed hypersensitivity to etoposide. Computed tomography (CT) revealed a 32‐mm solid mass in the right lung and a 101‐mm cystic mass with solid components in the left side of the liver. The patient's ser...
Gespeichert in:
Veröffentlicht in: | The journal of obstetrics and gynaecology research 2021-10, Vol.47 (10), p.3737-3741 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3741 |
---|---|
container_issue | 10 |
container_start_page | 3737 |
container_title | The journal of obstetrics and gynaecology research |
container_volume | 47 |
creator | Yamaguchi, Noriko Hamada, Yoshinobu Inagaki, Risa Nemoto, Kohei Yoshitomi, Hideyuki Takakura, Satoshi |
description | We report a 34‐year‐old woman with recurrent gestational trophoblastic neoplasia (GTN) who showed hypersensitivity to etoposide. Computed tomography (CT) revealed a 32‐mm solid mass in the right lung and a 101‐mm cystic mass with solid components in the left side of the liver. The patient's serum human chorionic gonadotropin (HCG) level was 689 439 mIU/mL. After eight cycles of combined paclitaxel 175 mg/m2 on day 1, ifosfamide 1 g/m2 on days 2–5, and cisplatin 20 mg/m2 on days 2–5 (TIP) every 3 weeks, the serum HCG level decreased to 2.4 mIU/mL. CT scan revealed disappearance of the lung tumor and significant reduction in the solid components of the liver tumor. Then, left hemihepatectomy was performed. After 3 months, there was no evidence of the disease, and the serum HCG level normalized. Thus, TIP chemotherapy, followed by residual mass resection, might be effective for methotrexate‐resistant GTN. |
doi_str_mv | 10.1111/jog.14945 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2578599356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2578599356</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3215-c9e9da5f7a7ca75bf218873ed643aa50a109bc04876423a925cb14947ae9315b3</originalsourceid><addsrcrecordid>eNp1kcFO3DAQhqOqlUppD30DS5wqEbCTOI6PFSrQColD23M0cSYbr7xx8Hh32RuPwHvxFjwJXrbiVmuksTTf_3vGk2VfBT8T6Zwv_eJMVLqS77IjUVUq50rW79O9rETecFV_zD4RLTkXSovmKHv6vTYGiYa1YwRuAwtkMSDEFU6RbW0c2QzG2Qj36E6ZHTwNsLI9njKYemYszQ6inVgKSGi0b7oVxtEnr3uI-PzwGJAsRUjVBaYcrZ_Apbf8PPrOAUVr2IQ-2ZEFth0963GDzs_Ys3E3YyCcyEa7sXHHUodm78CiZxj97Cm19Dn7MIAj_PIvH2d_L3_8ubjOb26vfl58v8lNWQiZG426BzkoUAaU7IZCNI0qsa-rEkByEFx3hleNqquiBF1I0-2_VAHqUsiuPM5ODr5z8HfrNEy79OuQpqG2kKqRWpeyTtS3A2WCJwo4tHOwKwi7VvB2v6ukWrSvu0rs-YHdWoe7_4Ptr9urg-IFhzieLw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2578599356</pqid></control><display><type>article</type><title>Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide</title><source>Wiley Online Library All Journals</source><creator>Yamaguchi, Noriko ; Hamada, Yoshinobu ; Inagaki, Risa ; Nemoto, Kohei ; Yoshitomi, Hideyuki ; Takakura, Satoshi</creator><creatorcontrib>Yamaguchi, Noriko ; Hamada, Yoshinobu ; Inagaki, Risa ; Nemoto, Kohei ; Yoshitomi, Hideyuki ; Takakura, Satoshi</creatorcontrib><description>We report a 34‐year‐old woman with recurrent gestational trophoblastic neoplasia (GTN) who showed hypersensitivity to etoposide. Computed tomography (CT) revealed a 32‐mm solid mass in the right lung and a 101‐mm cystic mass with solid components in the left side of the liver. The patient's serum human chorionic gonadotropin (HCG) level was 689 439 mIU/mL. After eight cycles of combined paclitaxel 175 mg/m2 on day 1, ifosfamide 1 g/m2 on days 2–5, and cisplatin 20 mg/m2 on days 2–5 (TIP) every 3 weeks, the serum HCG level decreased to 2.4 mIU/mL. CT scan revealed disappearance of the lung tumor and significant reduction in the solid components of the liver tumor. Then, left hemihepatectomy was performed. After 3 months, there was no evidence of the disease, and the serum HCG level normalized. Thus, TIP chemotherapy, followed by residual mass resection, might be effective for methotrexate‐resistant GTN.</description><identifier>ISSN: 1341-8076</identifier><identifier>EISSN: 1447-0756</identifier><identifier>DOI: 10.1111/jog.14945</identifier><language>eng</language><publisher>Kyoto, Japan: John Wiley & Sons Australia, Ltd</publisher><subject>Chemotherapy ; Chorionic gonadotropin ; Cisplatin ; Computed tomography ; Etoposide ; Gonadotropins ; HCG ; Hypersensitivity ; hypersensitivity reactions to etoposide ; Ifosfamide ; Liver ; Methotrexate ; methotrexate‐resistant GTN ; Paclitaxel ; Patients ; Pituitary (anterior) ; surgical resection ; TIP therapy</subject><ispartof>The journal of obstetrics and gynaecology research, 2021-10, Vol.47 (10), p.3737-3741</ispartof><rights>2021 Japan Society of Obstetrics and Gynecology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3215-c9e9da5f7a7ca75bf218873ed643aa50a109bc04876423a925cb14947ae9315b3</citedby><cites>FETCH-LOGICAL-c3215-c9e9da5f7a7ca75bf218873ed643aa50a109bc04876423a925cb14947ae9315b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjog.14945$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjog.14945$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27923,27924,45573,45574</link.rule.ids></links><search><creatorcontrib>Yamaguchi, Noriko</creatorcontrib><creatorcontrib>Hamada, Yoshinobu</creatorcontrib><creatorcontrib>Inagaki, Risa</creatorcontrib><creatorcontrib>Nemoto, Kohei</creatorcontrib><creatorcontrib>Yoshitomi, Hideyuki</creatorcontrib><creatorcontrib>Takakura, Satoshi</creatorcontrib><title>Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide</title><title>The journal of obstetrics and gynaecology research</title><description>We report a 34‐year‐old woman with recurrent gestational trophoblastic neoplasia (GTN) who showed hypersensitivity to etoposide. Computed tomography (CT) revealed a 32‐mm solid mass in the right lung and a 101‐mm cystic mass with solid components in the left side of the liver. The patient's serum human chorionic gonadotropin (HCG) level was 689 439 mIU/mL. After eight cycles of combined paclitaxel 175 mg/m2 on day 1, ifosfamide 1 g/m2 on days 2–5, and cisplatin 20 mg/m2 on days 2–5 (TIP) every 3 weeks, the serum HCG level decreased to 2.4 mIU/mL. CT scan revealed disappearance of the lung tumor and significant reduction in the solid components of the liver tumor. Then, left hemihepatectomy was performed. After 3 months, there was no evidence of the disease, and the serum HCG level normalized. Thus, TIP chemotherapy, followed by residual mass resection, might be effective for methotrexate‐resistant GTN.</description><subject>Chemotherapy</subject><subject>Chorionic gonadotropin</subject><subject>Cisplatin</subject><subject>Computed tomography</subject><subject>Etoposide</subject><subject>Gonadotropins</subject><subject>HCG</subject><subject>Hypersensitivity</subject><subject>hypersensitivity reactions to etoposide</subject><subject>Ifosfamide</subject><subject>Liver</subject><subject>Methotrexate</subject><subject>methotrexate‐resistant GTN</subject><subject>Paclitaxel</subject><subject>Patients</subject><subject>Pituitary (anterior)</subject><subject>surgical resection</subject><subject>TIP therapy</subject><issn>1341-8076</issn><issn>1447-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kcFO3DAQhqOqlUppD30DS5wqEbCTOI6PFSrQColD23M0cSYbr7xx8Hh32RuPwHvxFjwJXrbiVmuksTTf_3vGk2VfBT8T6Zwv_eJMVLqS77IjUVUq50rW79O9rETecFV_zD4RLTkXSovmKHv6vTYGiYa1YwRuAwtkMSDEFU6RbW0c2QzG2Qj36E6ZHTwNsLI9njKYemYszQ6inVgKSGi0b7oVxtEnr3uI-PzwGJAsRUjVBaYcrZ_Apbf8PPrOAUVr2IQ-2ZEFth0963GDzs_Ys3E3YyCcyEa7sXHHUodm78CiZxj97Cm19Dn7MIAj_PIvH2d_L3_8ubjOb26vfl58v8lNWQiZG426BzkoUAaU7IZCNI0qsa-rEkByEFx3hleNqquiBF1I0-2_VAHqUsiuPM5ODr5z8HfrNEy79OuQpqG2kKqRWpeyTtS3A2WCJwo4tHOwKwi7VvB2v6ukWrSvu0rs-YHdWoe7_4Ptr9urg-IFhzieLw</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Yamaguchi, Noriko</creator><creator>Hamada, Yoshinobu</creator><creator>Inagaki, Risa</creator><creator>Nemoto, Kohei</creator><creator>Yoshitomi, Hideyuki</creator><creator>Takakura, Satoshi</creator><general>John Wiley & Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>202110</creationdate><title>Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide</title><author>Yamaguchi, Noriko ; Hamada, Yoshinobu ; Inagaki, Risa ; Nemoto, Kohei ; Yoshitomi, Hideyuki ; Takakura, Satoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3215-c9e9da5f7a7ca75bf218873ed643aa50a109bc04876423a925cb14947ae9315b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Chemotherapy</topic><topic>Chorionic gonadotropin</topic><topic>Cisplatin</topic><topic>Computed tomography</topic><topic>Etoposide</topic><topic>Gonadotropins</topic><topic>HCG</topic><topic>Hypersensitivity</topic><topic>hypersensitivity reactions to etoposide</topic><topic>Ifosfamide</topic><topic>Liver</topic><topic>Methotrexate</topic><topic>methotrexate‐resistant GTN</topic><topic>Paclitaxel</topic><topic>Patients</topic><topic>Pituitary (anterior)</topic><topic>surgical resection</topic><topic>TIP therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamaguchi, Noriko</creatorcontrib><creatorcontrib>Hamada, Yoshinobu</creatorcontrib><creatorcontrib>Inagaki, Risa</creatorcontrib><creatorcontrib>Nemoto, Kohei</creatorcontrib><creatorcontrib>Yoshitomi, Hideyuki</creatorcontrib><creatorcontrib>Takakura, Satoshi</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>The journal of obstetrics and gynaecology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamaguchi, Noriko</au><au>Hamada, Yoshinobu</au><au>Inagaki, Risa</au><au>Nemoto, Kohei</au><au>Yoshitomi, Hideyuki</au><au>Takakura, Satoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide</atitle><jtitle>The journal of obstetrics and gynaecology research</jtitle><date>2021-10</date><risdate>2021</risdate><volume>47</volume><issue>10</issue><spage>3737</spage><epage>3741</epage><pages>3737-3741</pages><issn>1341-8076</issn><eissn>1447-0756</eissn><abstract>We report a 34‐year‐old woman with recurrent gestational trophoblastic neoplasia (GTN) who showed hypersensitivity to etoposide. Computed tomography (CT) revealed a 32‐mm solid mass in the right lung and a 101‐mm cystic mass with solid components in the left side of the liver. The patient's serum human chorionic gonadotropin (HCG) level was 689 439 mIU/mL. After eight cycles of combined paclitaxel 175 mg/m2 on day 1, ifosfamide 1 g/m2 on days 2–5, and cisplatin 20 mg/m2 on days 2–5 (TIP) every 3 weeks, the serum HCG level decreased to 2.4 mIU/mL. CT scan revealed disappearance of the lung tumor and significant reduction in the solid components of the liver tumor. Then, left hemihepatectomy was performed. After 3 months, there was no evidence of the disease, and the serum HCG level normalized. Thus, TIP chemotherapy, followed by residual mass resection, might be effective for methotrexate‐resistant GTN.</abstract><cop>Kyoto, Japan</cop><pub>John Wiley & Sons Australia, Ltd</pub><doi>10.1111/jog.14945</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1341-8076 |
ispartof | The journal of obstetrics and gynaecology research, 2021-10, Vol.47 (10), p.3737-3741 |
issn | 1341-8076 1447-0756 |
language | eng |
recordid | cdi_proquest_journals_2578599356 |
source | Wiley Online Library All Journals |
subjects | Chemotherapy Chorionic gonadotropin Cisplatin Computed tomography Etoposide Gonadotropins HCG Hypersensitivity hypersensitivity reactions to etoposide Ifosfamide Liver Methotrexate methotrexate‐resistant GTN Paclitaxel Patients Pituitary (anterior) surgical resection TIP therapy |
title | Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A42%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20salvage%20treatment%20with%20paclitaxel,%20ifosfamide,%20and%20cisplatin%20in%20a%20patient%20with%20methotrexate%E2%80%90resistant%20gestational%20trophoblastic%20neoplasia%20who%20developed%20hypersensitivity%20reaction%20to%20etoposide&rft.jtitle=The%20journal%20of%20obstetrics%20and%20gynaecology%20research&rft.au=Yamaguchi,%20Noriko&rft.date=2021-10&rft.volume=47&rft.issue=10&rft.spage=3737&rft.epage=3741&rft.pages=3737-3741&rft.issn=1341-8076&rft.eissn=1447-0756&rft_id=info:doi/10.1111/jog.14945&rft_dat=%3Cproquest_cross%3E2578599356%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2578599356&rft_id=info:pmid/&rfr_iscdi=true |